{"id":36326,"date":"2023-11-05T16:28:21","date_gmt":"2023-11-05T16:28:21","guid":{"rendered":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/?p=36326"},"modified":"2023-11-05T16:28:21","modified_gmt":"2023-11-05T16:28:21","slug":"using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor","status":"publish","type":"post","link":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/","title":{"rendered":"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor"},"content":{"rendered":"<div id=\"body-a00fc7a4-c005-49a4-b5e3-c337149ef7b1\" itemprop=\"articleBody\">\n<p>A brand new case report was published in <em>Oncoscience<\/em> (Volume 10) on September 20, 2023, entitled, &#8220;Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.&#8221;<\/p>\n<p>Ripretinib is a tyrosine kinase inhibitor that was approved by the USA FDA in 2020 for treatment of advanced gastrointestinal stromal tumor (GIST) in patients who received prior treatment with three or more tyrosine kinase inhibitors.<\/p>\n<p>On this recent case report, researchers <em>Mohamed A. Gouda, Filip Janku, Neeta Somaiah, Kelly K. Hunt, Sireesha Yedururi, <\/em>and<em> Vivek Subbiah<\/em> from The University of Texas MD Anderson Cancer Center and Sarah Cannon Research Institute described the usage of ripretinib in a patient with recurrent GIST harboring a KIT exon 11 mutation following treatment with multiple TKIs. The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to prolonged clinical profit.<\/p>\n<p><!-- end mobile middle mrec --><\/p>\n<p>&#8220;[&#8230;] we show the durable clinical profit achieved in a patient with GIST through the use of ripretinib and repeated timely surgical resection of limited disease progression.&#8221;<\/p>\n<p>A Hispanic female in her late 20s presented with left lower quadrant pain initially attributed to an ovarian cyst. A workup with computed tomography (CT) evaluation, revealed an incidental 6 cm duodenal mass with central necrosis. She underwent exploratory laparotomy with resection of the mass which was diagnosed as GIST with high malignant potential and positive immunohistochemistry for c-KIT. The whole time on ripretinib was 43 months which is longer than the present reported data from ripretinib clinical trials.<\/p>\n<p>&#8220;Such an approach for using multi-disciplinary disease management can improve the sturdiness of response to tyrosine kinase inhibitors, including ripretinib, and associated clinical outcomes.&#8221;<\/p>\n<div id=\"sources\" class=\"content-source below-content-common-a\">\n<p>Source:<\/p>\n<p>Journal reference:<\/p>\n<div class=\"content-src-value\">\n<p>Gouda, M. A., <em>et al.<\/em> (2023) Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery<em>.<\/em> <em>Onscience. <\/em><a href=\"http:\/\/doi.org\/10.18632\/oncoscience.586\" target=\"_blank\" rel=\"noopener\">doi.org\/10.18632\/oncoscience.586<\/a>.<\/p>\n<\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>A brand new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, &#8220;Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.&#8221; Ripretinib is a tyrosine kinase inhibitor that was approved by the USA FDA in 2020 for treatment of advanced [&#8230;]\n","protected":false},"author":1,"featured_media":36327,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"fifu_image_url":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg","fifu_image_alt":"","two_page_speed":[],"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[97],"tags":[397,3630,4282,4281,4283,2398,1982],"class_list":["post-36326","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-gastrointestinal","tag-manage","tag-recurrent","tag-ripretinib","tag-stromal","tag-surgery","tag-tumor"],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor - Daniels Marketing BLC<\/title>\n<meta name=\"description\" content=\"A brand new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, &quot;Multi-disciplinary management of recurrent\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor - Daniels Marketing BLC\" \/>\n<meta property=\"og:description\" content=\"A brand new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, &quot;Multi-disciplinary management of recurrent\" \/>\n<meta property=\"og:url\" content=\"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/\" \/>\n<meta property=\"og:site_name\" content=\"Daniels Marketing BLC\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-05T16:28:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg\" \/>\n<meta name=\"author\" content=\"info\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/\"},\"author\":{\"name\":\"info\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#\\\/schema\\\/person\\\/6a0a5d2e1a48d29297b62e635a4db33f\"},\"headline\":\"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor\",\"datePublished\":\"2023-11-05T16:28:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/\"},\"wordCount\":313,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d2jx2rerrg6sh3.cloudfront.net\\\/image-handler\\\/picture\\\/2014\\\/7\\\/174318220-620x480.jpg\",\"keywords\":[\"gastrointestinal\",\"Manage\",\"recurrent\",\"ripretinib\",\"stromal\",\"Surgery\",\"tumor\"],\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/\",\"url\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/\",\"name\":\"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor - Daniels Marketing BLC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d2jx2rerrg6sh3.cloudfront.net\\\/image-handler\\\/picture\\\/2014\\\/7\\\/174318220-620x480.jpg\",\"datePublished\":\"2023-11-05T16:28:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#\\\/schema\\\/person\\\/6a0a5d2e1a48d29297b62e635a4db33f\"},\"description\":\"A brand new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, \\\"Multi-disciplinary management of recurrent\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d2jx2rerrg6sh3.cloudfront.net\\\/image-handler\\\/picture\\\/2014\\\/7\\\/174318220-620x480.jpg\",\"contentUrl\":\"https:\\\/\\\/d2jx2rerrg6sh3.cloudfront.net\\\/image-handler\\\/picture\\\/2014\\\/7\\\/174318220-620x480.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/2023\\\/11\\\/05\\\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#website\",\"url\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/\",\"name\":\"Daniels Marketing BLC\",\"description\":\"All About Health &amp; Marketing\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/#\\\/schema\\\/person\\\/6a0a5d2e1a48d29297b62e635a4db33f\",\"name\":\"info\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g\",\"caption\":\"info\"},\"url\":\"https:\\\/\\\/danielsmarketingblc.com\\\/CuratedProducts\\\/author\\\/info\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor - Daniels Marketing BLC","description":"A brand new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, \"Multi-disciplinary management of recurrent","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/","og_locale":"en_US","og_type":"article","og_title":"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor - Daniels Marketing BLC","og_description":"A brand new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, \"Multi-disciplinary management of recurrent","og_url":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/","og_site_name":"Daniels Marketing BLC","article_published_time":"2023-11-05T16:28:21+00:00","og_image":[{"url":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg","type":"","width":"","height":""}],"author":"info","twitter_card":"summary_large_image","twitter_image":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg","twitter_misc":{"Written by":"info","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/#article","isPartOf":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/"},"author":{"name":"info","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#\/schema\/person\/6a0a5d2e1a48d29297b62e635a4db33f"},"headline":"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor","datePublished":"2023-11-05T16:28:21+00:00","mainEntityOfPage":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/"},"wordCount":313,"commentCount":0,"image":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/#primaryimage"},"thumbnailUrl":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg","keywords":["gastrointestinal","Manage","recurrent","ripretinib","stromal","Surgery","tumor"],"articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/","url":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/","name":"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor - Daniels Marketing BLC","isPartOf":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#website"},"primaryImageOfPage":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/#primaryimage"},"image":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/#primaryimage"},"thumbnailUrl":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg","datePublished":"2023-11-05T16:28:21+00:00","author":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#\/schema\/person\/6a0a5d2e1a48d29297b62e635a4db33f"},"description":"A brand new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, \"Multi-disciplinary management of recurrent","breadcrumb":{"@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/#primaryimage","url":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg","contentUrl":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/2023\/11\/05\/using-ripretinib-and-surgery-to-administer-recurrent-gastrointestinal-stromal-tumor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/"},{"@type":"ListItem","position":2,"name":"Using ripretinib and surgery to administer recurrent gastrointestinal stromal tumor"}]},{"@type":"WebSite","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#website","url":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/","name":"Daniels Marketing BLC","description":"All About Health &amp; Marketing","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/#\/schema\/person\/6a0a5d2e1a48d29297b62e635a4db33f","name":"info","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/387c3341fa426df253347bf8f03bf81e7c8355f511b0ffdb256b6fad73bc149c?s=96&d=mm&r=g","caption":"info"},"url":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/author\/info\/"}]}},"jetpack_featured_media_url":"https:\/\/d2jx2rerrg6sh3.cloudfront.net\/image-handler\/picture\/2014\/7\/174318220-620x480.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/posts\/36326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/comments?post=36326"}],"version-history":[{"count":2,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/posts\/36326\/revisions"}],"predecessor-version":[{"id":36329,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/posts\/36326\/revisions\/36329"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/media\/36327"}],"wp:attachment":[{"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/media?parent=36326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/categories?post=36326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/danielsmarketingblc.com\/CuratedProducts\/wp-json\/wp\/v2\/tags?post=36326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}